Skip to content

Bausch Health

US · BHC #2722 by market cap Listed 1970
8.22 -0.34 -3.97%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:46

Recent news

  • Rating change
    TD Cowen Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7
    Market Newswire · 2026/2/21
  • Rating change
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8
    Market Newswire · 2026/1/7
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Chemed (CHE), Bausch Health Companies (BHC) and CG Oncology, Inc. (CGON)
    TipRanks · 2026/4/27
  • Company notice
    MCOM: Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - BHC HOLDINGS SDN. BHD.
    Bursa Malaysia · 2026/6/5
  • Rating change
    Raymond James Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8
    Market Newswire · 2025/8/5
  • Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $9
    Market Newswire · 2026/11/11
  • Jefferies Initiates Bausch Health(BHC.US) With Hold Rating, Announces Target Price $8
    Market Newswire · 2026/10/30
  • Rating change
    RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $10
    Market Newswire · 2026/2/19
  • Rating change
    RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $9
    Market Newswire · 2026/4/27
  • Rating change
    Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC), Thermo Fisher (TMO) and Mineralys Therapeutics, Inc. (MLYS)
    TipRanks · 2025/10/30
  • Rating change
    BofA Securities Maintains Bausch Health(BHC.US) With Sell Rating, Maintains Target Price $5
    Market Newswire · 2026/2/19
  • Rating change
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating
    Market Newswire · 2026/2/19
  • Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7
    Market Newswire · 2026/10/29
  • Rating change
    Truist Financial Initiates Bausch Health(BHC.US) With Hold Rating
    Market Newswire · 2025/7/30
  • Rating change
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $8
    Market Newswire · 2026/1/24
  • RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $9
    Market Newswire · 2026/10/8
  • RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $10
    Market Newswire · 2026/10/29
  • Rating change
    A Quick Look at Today's Ratings for Bausch Health(BHC.US), With a Forecast Between $7 to $9
    Market Newswire · 2026/5/1
  • Rating change
    TR | OpenAI - 4o Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $5.81
    Market Newswire · 2025/8/11
  • Rating change
    Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Cuts Target Price to $7
    Market Newswire · 2026/2/25
  • GUIDANCE: (BHC) Bausch Health Now Expects Fiscal 2026 Revenue Range $10.98B - $11.18B, Vs. FactSet Est of $10.96B
    MT Newswires · 2026/10/29
  • Barclays Maintains Bausch Health(BHC.US) With Hold Rating, Maintains Target Price $7
    Market Newswire · 2026/6/4
  • Rating change
    Truist Financial Maintains Bausch Health(BHC.US) With Hold Rating, Announces Target Price $6.78
    Market Newswire · 2025/7/25
  • Earnings Call Summary | Bausch Health(BHC.US) Q1 2026 Earnings Conference
    Market Newswire · 2026/4/30
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Heart Test Laboratories, Inc. (HSCS) and Bausch Health Companies (BHC)
    TipRanks · 2025/7/29

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:46:13 · For reference only, not investment advice and not tailored to your situation.

Bausch Health discussion 0 comments

Add a comment